The problem with the historic MDL procedure (40CFR Part 136 Appendix B) was that in many ways the calculated MDL did not coincide with reality often significantly over-estimating the method's real sensitivity (the MDL being well below what the lab could actually see).
With your analyses for instance, when you run an MDL, we are quantitating from typically the primary ion, but to have a confirmed detect we need to be able to see the secondary ions. These may be only 10% of the base peak and will very often become no better than background noise at the calculated level of the MDL. Also, the MDL procedure is based upon the assumption that the slope of our calibration passes through the intercept. Now for volatiles most analytes probably are pretty close to this, but with semivolatiles, if you consider the nitrophenols, benzidine, etc., we very often do not have a zero intercept. In this case, we can run the spike, and so long as we have decent reproducibility, we get a low MDL - which is actually between the actual (positive) intercept of the line, and the zero. In other words, we end up with a detection limit that we fundamentally can't see.
Due to these issues, a lot of labs implemented secondary criteria to guard against having a calculated MDL which the lab knows it can't see. Whether it was by adopting recovery criteria, performing some type of spiked verification of the MDL, etc., it is not uncommon to see labs adopting secondary criteria.
Depending upon the State and your customer, they may have required secondary criteria that they would want to see you performing.